A5080878511- Palliative Care and End-of-Life Issues
- Lung Cancer Research Studies
- Patient-Provider Communication in Healthcare
- Cancer Diagnosis and Treatment
- Ethics in medical practice
- Advanced Radiotherapy Techniques
- Childhood Cancer Survivors' Quality of Life
- Patient Dignity and Privacy
- Cancer survivorship and care
- Viral-associated cancers and disorders
- Radiation Dose and Imaging
- Radiomics and Machine Learning in Medical Imaging
- Multiple and Secondary Primary Cancers
- Pharmaceutical Practices and Patient Outcomes
- Pharmacovigilance and Adverse Drug Reactions
- Lymphoma Diagnosis and Treatment
- Pharmaceutical Economics and Policy
- Neuroblastoma Research and Treatments
- Cancer Immunotherapy and Biomarkers
- Neuroendocrine Tumor Research Advances
Memorial Sloan Kettering Cancer Center
2019-2023
Albert Einstein College of Medicine
2020
Hospital Universitario de Móstoles
2013
PURPOSE Patient portal technology offers important new opportunities to support person-centered clinician-patient communication. METHODS Questionnaires relating understanding of illness and treatment intent were sent quarterly via all patients scheduled for follow-up in GI medical oncology clinics. For selected clinics, items eliciting health-related values added. responses available team members the electronic health record. Workflow content discussions about illness, treatment, care goals...
Somatostatin analogs octreotide long-acting release (octLAR) and lanreotide are equally acceptable in National Comprehensive Cancer Network guidelines for neuroendocrine tumors (NETs). Lanreotide is more expensive given by deep subcutaneous injection, whereas octLAR intramuscularly. We evaluated patient preference between these agents terms of injection site pain.Randomized, single-blinded study. Patients with NETs received injections every 4 weeks. Arm 1: × 3, then 3; arm 2: reverse order....
Abstract Background Thousands of patients annually receive treatment for advanced non-small cell lung cancer (NSCLC), but little is known about their views on the decision to that treatment, or regret. This trial prospectively evaluated incidence regret and whether baseline characteristics, patient decision-making parameters, clinical progress early in course predicts Materials Methods Patients receiving systemic NSCLC completed every 3-week reported outcome (PRO) assessment using electronic...
<h3>Background</h3> Elderly patients are likely to be served by different health professionals with the consequent appearance of polypharmacy, increased risk adverse drug reactions and hospital admissions. Therefore, we consider this population candidates for a medicines reconciliation process. <h3>Purpose</h3> To identify type, frequency severity discrepancies between prescribed during admission their chronic investigate involved in errors. <h3>Materials Methods</h3> Retrospective...
<h3>Background</h3> HIV infection is associated with increased risk of cancer: AIDS-defining cancers (ADC): Kaposi’s sarcoma (KS), non-Hodgkin lymphoma (NHL), cervix cancer. non-AIDS-defining (NADC): Hodgkin (HL), anal cancer, lung, head, neck, hepatocarcinoma. <h3>Purpose</h3> To analyse patients antiretroviral therapy and chemotherapy, type cancer factors. <h3>Materials Methods</h3> Descriptive study chemotherapy between 2004–2011, extracting data from medical records the Farmatools...